AOP Health and VRG Therapeutics Enter Co-Development Partnership for New Immunology Program – source AOP Health VIENNA, Austria and BUDAPEST, Hungary, May 12, 2026 / Biotech Newswire / — AOP Health, a global pharmaceutical enterprise group focused on integrated therapies for rare diseases and critical care, today announced a strategic partnership with VRG Therapeutics, an AI-driven developer for […]
Ljubljana / Budapest – 20.2.2026 – GenePlanet d.o.o., a leading European genomics company specialising in genetic testing, has acquired New Era Genetics, a Hungarian genetic testing company based in Budapest, from Vascular Group. The acquisition represents a strategic step in GenePlanet’s continued expansion across Central and Eastern Europe and strengthens its local presence, laboratory capabilities and […]
Press release BUDAPEST, HUNGARY, February 20, 2024/ EINPresswire.com/ — VRG Therapeutics(VRG Tx), a biotechnology R&D company focusing on miniprotein pharmaceuticals and cellular & gene therapy (CGT) products has announced the successful experimental verification of its proprietary, artificial intelligence-(AI)-powered drug discovery technology. Using the company’s established, directed evolution based miniprotein platform, VRG Tx has previously demonstrated […]
We are pleased to inform you that based on the jury’s opinion, VRGT was selected in the Global Startup Awards program among the best emerging companies in Central Europe (CE) in two categories: Startup of the Year 2023 & Newcomer of the Year 2023! The category winners within CE will be announced in January, 2024, […]
We are proud to share that our Managing Director, Zalán Péterfi has participated at the second roundtable of MBH Bank’s Macronome Macroverse conference, where the results and challenges of the Hungarian innovation ecosystem and Hungary’s position in European terms were discussed. Participants also talked about how to improve Hungary’s innovation and technology situation.
We are happy to announce that Ádám Jenőfalvi, a student researcher at VRG Therapeutics won first prize at the student association conference („TDK”) at Budapest University of Technology and Economics in Section Biotechnology, Biochemistry and Food Sciences. His thesis describes the engineering of a recombinant live biotherapeutic product (rLBP) to treat inflammatory bowel diseases. Congratulations […]
We are happy and thrilled to announce that our Kv1.3 pitch was chosen as “Best Innovative Business Proposal” by a board of investors on Startup Breeding, an annual event of Cluster Nazionale Scienze della Vita ALISEI, the Italian National Cluster for Life Sciences. Furthermore, we received the Special Awards of 2i3T – Innovative Companies Incubator […]
We are proud to be part of the BIO-Europe 2023 Startup Spotlight as one of the selected companies! It’s a privilege to share the stage with such forward-thinking biotech startups.
We are thrilled to announce that VRG Therapeutics has been selected to present in front of top-tier VC investors in the Startup Spotlight competition at Bio Europe 2023, organized with the support of Bayer Co.Lab incubator. We pitch our Kv1.3 asset aiming to cure autoimmune diseases. You’ll have the opportunity to meet with Zalán Péterfi […]
Our colleague, Patrik Szekér participated in the International Biotech Days 2023 organized by the Hungarian Biotechnology Student Association, and gave a talk on our Kv1.3 asset aiming to cure autoimmune diseases. The event was supported by VRG Therapeutics.
